Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 703

1.

New antiresorptive therapies for postmenopausal osteoporosis.

Choi HJ.

J Menopausal Med. 2015 Apr;21(1):1-11. doi: 10.6118/jmm.2015.21.1.1. Epub 2015 Apr 27. Review.

2.

Comparison of Buckling Ratio and Finite Element Analysis of Femoral Necks in Post-menopausal Women.

Anitha D, Kim KJ, Lim SK, Lee T.

J Menopausal Med. 2014 Aug;20(2):52-6. doi: 10.6118/jmm.2014.20.2.52. Epub 2014 Aug 27.

3.

TNFRSF11B gene polymorphisms, bone mineral density, and fractures in Slovak postmenopausal women.

Boroňová I, Bernasovská J, Mačeková S, Petrejčíková E, Tomková Z, Kľoc J, Poráčová J, Blaščáková MM, Litavcová E.

J Appl Genet. 2015 Feb;56(1):57-63. doi: 10.1007/s13353-014-0247-4. Epub 2014 Oct 17.

PMID:
25323794
4.

Bone density in black and white South African women: contribution of ethnicity, body weight and lifestyle.

Conradie M, Conradie MM, Kidd M, Hough S.

Arch Osteoporos. 2014;9:193. doi: 10.1007/s11657-014-0193-0. Epub 2014 Sep 5.

PMID:
25190256
5.

Trabecular bone score: perspectives of an imaging technology coming of age.

Silva BC, Bilezikian JP.

Arq Bras Endocrinol Metabol. 2014 Jul;58(5):493-503. Review.

6.

Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids.

Sutter S, Nishiyama KK, Kepley A, Zhou B, Wang J, McMahon DJ, Guo XE, Stein EM.

J Clin Endocrinol Metab. 2014 Nov;99(11):4231-40. doi: 10.1210/jc.2014-2177. Epub 2014 Aug 15.

PMID:
25127089
7.

Association between bone mineral density and clinical consequences: cross-sectional study of Korean postmenopausal women in an orthopaedic outpatient clinic.

Lee JH, Lee YH, Moon SH; TOP Study Group.

J Korean Med Sci. 2014 Aug;29(8):1152-60. doi: 10.3346/jkms.2014.29.8.1152. Epub 2014 Jul 30.

8.

Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.

Moberg LM, Nilsson PM, Samsioe G, Borgfeldt C.

Maturitas. 2014 Aug;78(4):310-5. doi: 10.1016/j.maturitas.2014.05.019. Epub 2014 Jun 2.

PMID:
24958166
9.

Vitamin K and musculoskeletal health in postmenopausal women.

Hamidi MS, Cheung AM.

Mol Nutr Food Res. 2014 Aug;58(8):1647-57. doi: 10.1002/mnfr.201300950. Epub 2014 Jun 23. Review.

PMID:
24956598
10.

Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning.

Stein EM, Kepley A, Walker M, Nickolas TL, Nishiyama K, Zhou B, Liu XS, McMahon DJ, Zhang C, Boutroy S, Cosman F, Nieves J, Guo XE, Shane E.

J Bone Miner Res. 2014;29(5):1101-9.

11.

Vitamin K₂ therapy for postmenopausal osteoporosis.

Iwamoto J.

Nutrients. 2014 May 16;6(5):1971-80. doi: 10.3390/nu6051971. Review.

12.

Treatment of osteoporosis in older adults.

Gosch M, Kammerlander C, Nicholas JA.

Panminerva Med. 2014 Jun;56(2):133-43. Epub 2014 May 12. Review.

PMID:
24820095
13.

The prevention of postmenopausal osteoporotic fractures: results of the Health Technology Assessment of a new antiosteoporotic drug.

de Waure C, Specchia ML, Cadeddu C, Capizzi S, Capri S, Di Pietro ML, Veneziano MA, Gualano MR, Kheiraoui F, La Torre G, Nicolotti N, Sferrazza A, Ricciardi W.

Biomed Res Int. 2014;2014:975927. doi: 10.1155/2014/975927. Epub 2014 Feb 4.

14.

Early changes in bone density, microarchitecture, bone resorption, and inflammation predict the clinical outcome 12 weeks after conservatively treated distal radius fractures: an exploratory study.

Meyer U, de Jong JJ, Bours SG, Keszei AP, Arts JJ, Brink PR, Menheere P, van Geel TA, van Rietbergen B, van den Bergh JP, Geusens PP, Willems PC.

J Bone Miner Res. 2014 Sep;29(9):2065-73. doi: 10.1002/jbmr.2225.

PMID:
24644096
15.

Vitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal women.

Li S, Ou Y, Zhang H, Zhang Z, Zhou H, Liu L, Sheng Z, Liao E.

Ann Nutr Metab. 2014;64(1):13-9. doi: 10.1159/000358340. Epub 2014 Mar 13.

PMID:
24642634
16.

Fracture incidence after 3 years of aromatase inhibitor therapy.

Bouvard B, Soulié P, Hoppé E, Georgin-Mege M, Royer M, Mesgouez-Nebout N, Lassalle C, Cellier P, Jadaud E, Abadie-Lacourtoisie S, Tuchais C, Vinchon-Petit S, Audran M, Chappard D, Legrand E.

Ann Oncol. 2014 Apr;25(4):843-7. doi: 10.1093/annonc/mdu008. Epub 2014 Mar 7.

17.

Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment.

Gómez-de-Tejada Romero MJ, Navarro Rodríguez MD, Saavedra Santana P, Quesada Gómez JM, Jódar Gimeno E, Sosa Henríquez M.

Maturitas. 2014 Mar;77(3):282-6. doi: 10.1016/j.maturitas.2013.12.011. Epub 2014 Jan 7.

PMID:
24529318
18.

Changes of paraspinal muscles in postmenopausal osteoporotic spinal compression fractures: magnetic resonance imaging study.

Kim JY, Chae SU, Kim GD, Cha MS.

J Bone Metab. 2013 Nov;20(2):75-81. doi: 10.11005/jbm.2013.20.2.75. Epub 2013 Nov 18.

19.

THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women.

Gogakos A, Logan JG, Waung JA, Bassett JH, Glüer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR.

Eur J Endocrinol. 2014 Mar 13;170(4):637-44. doi: 10.1530/EJE-13-1009. Print 2014 Apr.

20.

[Expert group consensus: prevention, diagnosis and treatment of bone loss and osteoporosis in postmenopausal breast cancer patients after aromatase inhibitor therapy].

Xiu Bing-He; Consensus Expert Group For Prevention Diagnosis And Treatment Of Bone Loss And Osteoporosis In Postmenopausal Breast Cancer Patients After Aromatase Inhibitor Therapy.

Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):876-9. Chinese. No abstract available.

PMID:
24447490
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk